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To the Editor,
According to the WHO classification of acute leu-
kemia,  diagnosis  is  based  on  an  arbitrary  cut-off 
point of 20% blasts, as the percentage of bone mar-
row total or non-erythroid cells, or as the percentage 
of peripheral blood cells. This cut-off point is also cur-
rently used in under-resourced laboratories in which 
the FAB classification is more commonly used.
This cut-off point seems to be universally accept-
ed,  and  for  the  time  being  represents  the  best-
known criterion for defining acute leukemia; how-
ever, “arbitrary” may still precede the criterion due 
to the follow:
1. This percentage does not represent a specific bio-
logical  event  in  the  continuum  of  an  increasing 
blast count, but is merely, to the best to our knowl-
edge, a cut-off point that facilitates relatively clear 
classification  and  therapeutic  planning. 
Nonetheless,  some  high-risk  MDS  patients  with 
only 10% bone marrow blasts are actively treated.
2. A significant difference in the blast percentage 
cut-off  point  between  peripheral  blood  and 
bone marrow is well established in MDS; RAEB-
1  (blast  count  <5%  in  peripheral  blood  and 
5%-9%  in  bone  marrow)  and  RAEB-2  (blast 
count of 5%-9% in peripheral blood and 10%-
19% in bone marrow). In acute leukemia no 
such differentiation exits.
3. Morphological findings of pathological “clonal” 
blasts (type II that contain Auer rods, Pseudo-
Chédiak-Higashi  or  other  specific  inclusions 
that are not seen in reactive marrow) refer to 
the diagnosis of RAEB-2 or AML; here again the 
arbitrary cut-off point of 20% blasts results in a 
specific diagnosis.
4. The original FAB classification was based for 
many years on the arbitrary cut-off point of 30% 
bone  marrow  blasts  and  in  the  past  some 
patients with 20%-29% blasts remained stable 
for months without chemotherapy.
5. Although  there  is  a  general  consensus  con-
cerning the criterion for identifying myeloblasts 
as agranular (type I) and granular blasts (types 
II  and  III),  there  is  some  disagreement  con-
cerning their definitions, and in practice it may 
be a matter of convention (subjective method) 
to  differentiate  them  from  the  continuum  of 
cells, such as determining whether the cell is a 
type III blast or a promyelocyte.
6. Blasts  refer  to  myeloblasts,  lymphoblasts, 
monoblasts,  promonocytes,  and  megakaryo-
blasts.7. Diagnosis  of  AML-M3  and  its  variant  is  not 
related to the percentage of blasts.
8. Cases with <20% blast cells may still be diag-
nosed as acute leukemia if they present with 
certain recurrent cytogenetic abnormalities, as 
in AML M4 with inv (16) or t (16;16) (p13;q22) 
and AML M2 with t (8;21).
9. The utilization of a 20% blast threshold is not 
really an issue in ALL because most patients at 
the time of diagnosis already have <50% blasts. 
In AML-M0 and M1 this cut-off point is also not 
useful.
In conclusion: Morphology is the first-line diag-
nostic criterion for acute leukemia; however, labo-
ratory  diagnosis  of  acute  leukemia  in  modern 
hematologic practice increasingly relies on objec-
tive techniques to detect a specific ultrastructural or 
genetic abnormality. As such, the era of 20% blasts 
as a diagnostic criterion for acute leukemia may not 
stand the time any longer than that of the old FAB 
group 30% blasts lower threshold.
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